|
|
Volumn 11, Issue 4, 2015, Pages 206-213
|
|
Current and Future Treatment of Hypertension in the SPRINT Era
|
|
Author keywords
blood pressure; essential hypertension; guidelines; masked hypertension; SPRINT study
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ALGORITHM;
BLOOD PRESSURE;
BLOOD PRESSURE MONITORING;
CARDIOVASCULAR DISEASES;
CLINICAL PATHWAY;
CLINICAL TRIAL (TOPIC);
COMBINATION DRUG THERAPY;
DRUG EFFECTS;
DRUG RESISTANCE;
EVIDENCE BASED MEDICINE;
HUMAN;
HYPERTENSION;
PATHOPHYSIOLOGY;
PRACTICE GUIDELINE;
PREDICTIVE VALUE;
RISK ASSESSMENT;
RISK FACTOR;
TREATMENT OUTCOME;
ALGORITHMS;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
BLOOD PRESSURE MONITORING, AMBULATORY;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS AS TOPIC;
CRITICAL PATHWAYS;
DRUG RESISTANCE;
DRUG THERAPY, COMBINATION;
EVIDENCE-BASED MEDICINE;
HUMANS;
HYPERTENSION;
PRACTICE GUIDELINES AS TOPIC;
PREDICTIVE VALUE OF TESTS;
RISK ASSESSMENT;
RISK FACTORS;
TREATMENT OUTCOME;
|
|
EID: 85018294914
PISSN: None
EISSN: 19476108
Source Type: Journal
DOI: 10.14797/mdcj-11-4-206 Document Type: Review |
|
Times cited : (7)
|
|
References (0)
|